Biotech Acquisition Co Stock Net Asset
| BIOTDelisted Stock | USD 10.15 0.00 0.00% |
Biotech Acquisition Co fundamentals help investors to digest information that contributes to Biotech Acquisition's financial success or failures. It also enables traders to predict the movement of Biotech Stock. The fundamental analysis module provides a way to measure Biotech Acquisition's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biotech Acquisition stock.
Biotech |
Biotech Acquisition Co Company Net Asset Analysis
Biotech Acquisition's Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Current Biotech Acquisition Net Asset | 230 |
Most of Biotech Acquisition's fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biotech Acquisition Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
CompetitionBased on the recorded statements, Biotech Acquisition Co has a Net Asset of 230. This is much higher than that of the Financial Services sector and significantly higher than that of the Shell Companies industry. The net asset for all United States stocks is notably lower than that of the firm.
Biotech Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biotech Acquisition's direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Biotech Acquisition could also be used in its relative valuation, which is a method of valuing Biotech Acquisition by comparing valuation metrics of similar companies.Biotech Acquisition is currently under evaluation in net asset category among its peers.
Biotech Fundamentals
| Return On Asset | -0.0085 | |||
| Current Valuation | 290.09 M | |||
| Shares Outstanding | 23 M | |||
| Shares Owned By Institutions | 100.00 % | |||
| Number Of Shares Shorted | 9.3 K | |||
| Price To Earning | 29.21 X | |||
| Price To Book | 1.33 X | |||
| EBITDA | (6.86 M) | |||
| Net Income | (6.86 M) | |||
| Cash And Equivalents | 1.7 K | |||
| Total Debt | 153.35 K | |||
| Debt To Equity | 3.48 % | |||
| Current Ratio | 0.04 X | |||
| Book Value Per Share | (0.46) X | |||
| Cash Flow From Operations | (1.47 M) | |||
| Short Ratio | 0.05 X | |||
| Earnings Per Share | 0.26 X | |||
| Market Capitalization | 291.81 M | |||
| Total Asset | 230 | |||
| Net Asset | 230 |
About Biotech Acquisition Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biotech Acquisition Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biotech Acquisition using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biotech Acquisition Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Consideration for investing in Biotech Stock
If you are still planning to invest in Biotech Acquisition check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biotech Acquisition's history and understand the potential risks before investing.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |